Conference abstract · 13 Oct 2016
Conference abstractPublished 14 Sep 2015
Nonthermal plasma-treated solutions as antimicrobial agents in control of multi-drug resistant pathogens
Drexel University College of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Multi-drug resistance in bacterial pathogens (MDRO) is a significant challenge that healthcare facilities faces globally. Surface-associated biofilms often act as reservior of MDRO and a source of dissemination of resistance. MDRO in biofilm form requires much higher doses of antimicrobial biocides than their planktonic counterpart. Such doses are often cytotoxic, and can not be repeatedly used. Additionally, an increase in resistant phenotypes due to spontaneous mutations challenges traditional antibiotics and other antimicrobial agents. Nonthermal plasma treatments are increasingly used in disinfection and sterilization, in different forms of applications, such as direct plasma application over the surface or first treating the liquid of interest, and then applying it over surface (animate or inanimate). Aqueous solutions treated by plasma at atmosphere air contains a complex cocktail of reactive species such as hydrogen peroxide, superoxide, nitric oxide, nitrogen dioxide, nitrite and nitrate, and typically have a low pH (which helps in stabilizing some of these species). All these species are physiologically reactive and known to kill bacteria in suspension by exerting a synergistic antimicrobial effect. Recently, we demonstrated that nonthermal plasma (plasma)-treated solutions acquire strong stable antimicrobial activity, and these solutions have a rapid and broad spectrum activity against multidrug resistant bacterial pathogens. This activity is retained for at least two years at room temperature, and the solution(s) exhibit appreciable toxicity. The proposed research presents the understanding of the mechanisms underlying the bactericidal effect of one of the plasma-activated antimicrobial solution, using E. coli’s physiological responses as the probe.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Jul 2017
Influence of antibiotic resistance on plasma susceptibility of multi-drug resistant clinical isolates of enterococci
Conference abstract · 14 Jun 2018
Overcoming antibiotic resistance: Inhibition of ld-transpeptidation in multi-drug resistant pathogens
Conference abstract · 31 Jul 2017
Nanotechnology for combating multi-drug resistance: A next generation antimicrobial therapy
Conference abstract · 31 Jul 2017
Application of small synthetic antimicrobial peptides (ssAMP) to control antibiotics resistant pathogens of citrus canker disease
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Short communication · 30 Dec 2025
Liver Drug Metabolism Mechanisms Challenges and Future Perspectives
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Suresh G Joshi”
- BylineArticles whose byline prints “Utku Ercan”
- BylineArticles whose byline prints “Adam Yost”
- BylineArticles whose byline prints “Siddharth Joshi”
- BylineArticles whose byline prints “Nachiket Vaze”
- BylineArticles whose byline prints “Brandon Fong”
- BylineArticles whose byline prints “Michael Neidrauer”

